Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1136860

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1136860

Protein Expression Market by Type (E.Coli, Mammalian, CHO, HEK 293, Insect, Pichia, Cell-free), Products (Reagents, Vectors, Competent Cells, Instruments, Service), Application (Therapeutic, Industrial), End User, and Region - Global Forecast to 2027

PUBLISHED:
PAGES: 314 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

The global Protein Expression market is valued at an estimated USD 2.9 billion in 2022 and is projected to reach USD 5.4 billion by 2027, at a CAGR of 13.3% during the forecast period. Factors such as the growth in the life science and biopharmaceutical industries, increasing research activities on recombinant-based protein expression, and the availability of funding for protein-based research. However, the high cost of protein expression reagents and instruments is expected to restrain the growth of this market.

"The Prokaryotic Expression system segment accounted for the highest growth rate in the Protein Expression market, by System Type, during the forecast period"

In 2021, the Prokaryotic Expression system segment accounted for the highest growth rate. Factors such as high level of protein production at a minimal cost, and their increasing applications in biologics production will favor the growth of this market.

"Asia Pacific: The fastest-growing region in the Protein Expression market"

The Asia Pacific market is estimated to record the highest CAGR during the forecast period. The high growth rate of this market can be attributed to the rapid growth of the biotechnology industry, the rising prevalence of chronic disorders, increasing investments by governments in protein-based research, and rising awareness about personalized therapeutics. Besides, global players are focused on this region for the low-cost manufacturing advantage that it provides.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side- 60% and Demand Side 40%
  • By Designation: C-level (Managers) - 45%, D-level (CXOs, Directors)- 30%, and Others (Executives) - 25%
  • By Region: North America -20%, Europe -10%, Asia-Pacific -55%, Latin America -10%, Middle East & Africa- 5%

List of Companies Profiled in the Report:

  • Thermo Fisher Scientific, Inc (US)
  • Merck KGaA (Germany)
  • GenScript Biotech Corporation (US)
  • Agilent Technologies, Inc. (US)
  • Takara Bio, Inc. (Japan)
  • Bio-Rad Laboratories, Inc. (US)
  • Qiagen N.V (Netherlands)
  • Charles River Laboratories, Inc. (US)
  • Danaher Corporation (US)
  • Sartorius AG (Germany)
  • Corning Incorporated (US)
  • FUJIFILM Irvine Scientific, Inc. (Japan)
  • Lonza Group AG (Switzerland)
  • Bioneer Corporation (South Korea)
  • Promega Corporation (US)
  • Oxford Expression Technologies Ltd. (UK)
  • ProteoGenix (France)
  • Abeomics, Inc. (US)
  • New England Biolabs, Inc. (US)
  • Promab Biotechnologies (US)
  • Sino Biological, Inc. (China)
  • Jena Bioscience (Germany)
  • Lifesensors, Inc. (US)
  • Leading biology, Inc. (US)
  • Peak Proteins (UK)

Research Coverage:

This report provides a detailed picture of the global Protein Expression Market. It aims at estimating the size and future growth potential of the market across different segments such as the system type, product & service, application, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall Protein Expression Market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, challenges, restraints, trends, and opportunities.

Product Code: BT 2435

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 BREAKDOWN OF PRIMARIES
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • FIGURE 3 PROTEIN EXPRESSION MARKET SIZE ESTIMATION (SUPPLY SIDE ANALYSIS), 2021
    • FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2021
    • 2.2.1 INSIGHTS FROM PRIMARY EXPERTS
    • FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
  • 2.3 MARKET GROWTH RATE PROJECTIONS
    • FIGURE 6 PROTEIN EXPRESSION MARKET (SUPPLY SIDE): CAGR PROJECTIONS
    • FIGURE 7 PROTEIN EXPRESSION MARKET (DEMAND SIDE): GROWTH ANALYSIS OF FACTORS
    • 2.3.1 DATA TRIANGULATION
    • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • 2.4 RESEARCH ASSUMPTIONS
    • 2.4.1 COVID-19-SPECIFIC ASSUMPTIONS
  • 2.5 RISK ANALYSIS

3 EXECUTIVE SUMMARY

    • FIGURE 9 PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 10 PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    • FIGURE 11 PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 12 PROTEIN EXPRESSION MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    • FIGURE 13 GEOGRAPHICAL SNAPSHOT OF PROTEIN EXPRESSION MARKET

4 PREMIUM INSIGHTS

  • 4.1 PROTEIN EXPRESSION MARKET OVERVIEW
    • FIGURE 14 INCREASING DEMAND FOR PROTEIN BIOLOGICS TO DRIVE MARKET
  • 4.2 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE AND COUNTRY (2021)
    • FIGURE 15 US TO COMMAND LARGEST SHARE OF NORTH AMERICAN PROTEIN EXPRESSION MARKET IN 2021
  • 4.3 PROTEIN EXPRESSION MARKET SHARE, BY SYSTEM TYPE, 2022 VS. 2027
    • FIGURE 16 MAMMALIAN CELL EXPRESSION SYSTEM TO DOMINATE MARKET IN 2027
  • 4.4 PROTEIN EXPRESSION MARKET SHARE, BY END USER, 2022
    • FIGURE 17 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO BE LARGEST END USERS
  • 4.5 PROTEIN EXPRESSION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 18 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 19 PROTEIN EXPRESSION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing demand for protein biologics
    • TABLE 1 BIOLOGICS AND CELL LINES USED
    • TABLE 2 BIOLOGICS APPROVED BY FDA IN 2021
    • TABLE 3 PROTEINS SYNTHESIZED BY PROTEIN EXPRESSION AND GENETIC ENGINEERING
    • FIGURE 20 DIABETES CASES, BY REGION, 2021 VS. 2045 (MILLION)
    • TABLE 4 GLOBAL INCIDENCE OF CANCER, BY TYPE (2020)
      • 5.2.1.2 Increasing R&D in pharmaceutical and biopharmaceutical industries
      • 5.2.1.3 Growing adoption of recombinant-based protein expression
      • 5.2.1.4 Availability of funding for protein-based research
    • TABLE 5 GOVERNMENT FUNDING FOR PROTEIN-BASED RESEARCH (2017-2022)
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of protein expression reagents and instruments
    • TABLE 6 AVERAGE SELLING PRICE OF DIFFERENT TYPES OF MEDIA/1000 L IN DEVELOPED AND DEVELOPING COUNTRIES (2020)
      • 5.2.2.2 Increasing consolidation and high barriers for new entrants
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Emergence of microfluidics
      • 5.2.3.2 Emerging economies offering significant growth potential
    • 5.2.4 CHALLENGE
      • 5.2.4.1 Undesired post-translational modifications and purification
  • 5.3 RANGES/SCENARIOS
    • FIGURE 21 SPECTRUM OF SCENARIOS BASED ON IMPACT OF UNCERTAINTIES ON GROWTH OF PROTEIN EXPRESSION MARKET
    • FIGURE 22 TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.4 PRICING ANALYSIS
  • 5.5 TECHNOLOGY ANALYSIS
    • TABLE 7 ADVANTAGES AND CHALLENGES OF RECOMBINANT PROTEIN EXPRESSION SYSTEMS
  • 5.6 PATENT ANALYSIS
    • FIGURE 23 PATENT APPLICATIONS FOR PROTEIN EXPRESSION MARKET, JANUARY 2011-MAY 2022
    • TABLE 8 INDICATIVE PATENT IN PROTEIN EXPRESSION MARKET
  • 5.7 VALUE CHAIN ANALYSIS
    • FIGURE 24 VALUE CHAIN ANALYSIS: RAW MATERIAL AND MANUFACTURING PHASE TO CONTRIBUTE MAXIMUM VALUE
  • 5.8 SUPPLY CHAIN ANALYSIS
    • FIGURE 25 PROTEIN EXPRESSION MARKET: SUPPLY CHAIN ANALYSIS
  • 5.9 ECOSYSTEM ANALYSIS
    • TABLE 9 SUPPLY CHAIN ECOSYSTEM
  • 5.10 KEY CONFERENCES AND EVENTS IN 2022-2023
    • TABLE 10 PROTEIN EXPRESSION MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
  • 5.11 REGULATORY ANALYSIS
    • 5.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 11 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 12 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 13 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 14 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.12 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 15 PROTEIN EXPRESSION MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.12.1 THREAT OF NEW ENTRANTS
    • 5.12.2 THREAT OF SUBSTITUTES
    • 5.12.3 BARGAINING POWER OF SUPPLIERS
    • 5.12.4 BARGAINING POWER OF BUYERS
  • 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 26 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF PROTEIN EXPRESSION PRODUCTS AND SERVICES
    • 5.13.2 BUYING CRITERIA FOR PROTEIN EXPRESSION PRODUCTS
    • FIGURE 27 KEY BUYING CRITERIA FOR END USERS

6 PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE

  • 6.1 INTRODUCTION
    • TABLE 16 PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020-2027 (USD MILLION)
  • 6.2 MAMMALIAN CELL EXPRESSION SYSTEMS
    • TABLE 17 PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 18 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 19 EUROPE: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 20 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 21 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 22 MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • 6.2.1 CHINESE HAMSTER OVARY CELL SYSTEMS (CHO CELL SYSTEMS)
      • 6.2.1.1 Chinese hamster ovary cell systems to dominate market
    • TABLE 23 PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 24 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 25 EUROPE: PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 26 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 27 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY REGION, 2020-2027 (USD MILLION)
    • 6.2.2 HUMAN EMBRYONIC KIDNEY CELL SYSTEMS (HEK 293 CELL SYSTEMS)
      • 6.2.2.1 Increasing use of HEK 293 cells for producing biologics to boost market
    • TABLE 28 PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 29 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 30 EUROPE: PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 31 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 32 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY REGION, 2020-2027 (USD MILLION)
    • 6.2.3 OTHER MAMMALIAN CELL SYSTEMS
    • TABLE 33 PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL SYSTEMS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 34 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 35 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 36 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 37 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL SYSTEMS, BY REGION, 2020-2027 (USD MILLION)
  • 6.3 PROKARYOTIC EXPRESSION SYSTEMS
    • TABLE 38 PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 39 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 40 EUROPE: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 41 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 42 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 43 PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • 6.3.1 ESCHERICHIA COLI SYSTEMS
      • 6.3.1.1 Increasing use of E. coli systems for commercial protein production to fuel market
    • TABLE 44 PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 45 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 46 EUROPE: PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 47 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 48 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY REGION, 2020-2027 (USD MILLION)
    • 6.3.2 OTHER PROKARYOTIC EXPRESSION SYSTEMS
    • TABLE 49 PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 50 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 51 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 52 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 53 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2020-2027 (USD MILLION)
  • 6.4 INSECT CELL EXPRESSION SYSTEMS
    • TABLE 54 PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 55 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 56 EUROPE: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 57 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 58 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 59 INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • 6.4.1 BACULOVIRUS SYSTEMS
      • 6.4.1.1 Baculovirus systems to show high yield and expression levels for intracellular proteins
    • TABLE 60 PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 61 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 62 EUROPE: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 63 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 64 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY REGION, 2020-2027 (USD MILLION)
    • 6.4.2 OTHER INSECT CELL SYSTEMS
    • TABLE 65 PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 66 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 67 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 68 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 69 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY REGION, 2020-2027 (USD MILLION)
  • 6.5 YEAST EXPRESSION SYSTEMS
    • TABLE 70 PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 71 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 72 EUROPE: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 73 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 74 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 75 YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • 6.5.1 PICHIA SYSTEMS
      • 6.5.1.1 Pichia systems to hold largest market share
    • TABLE 76 PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 77 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 78 EUROPE: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 79 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 80 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY REGION, 2020-2027 (USD MILLION)
    • 6.5.2 SACCHAROMYCES SYSTEMS
      • 6.5.2.1 Saccharomyces systems to channelize direction of foreign proteins into secretory pathways using various signals
    • TABLE 81 PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 82 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 83 EUROPE: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 84 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 85 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY REGION, 2020-2027 (USD MILLION)
    • 6.5.3 OTHER YEAST EXPRESSION SYSTEMS
    • TABLE 86 PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 87 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 88 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 89 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 90 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY REGION, 2020-2027 (USD MILLION)
  • 6.6 CELL-FREE EXPRESSION SYSTEMS
    • 6.6.1 INCREASING DEMAND FOR RECOMBINANT PROTEINS TO SUPPORT MARKET
    • TABLE 91 PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 92 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 93 EUROPE: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 94 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 95 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY REGION, 2020-2027 (USD MILLION)
  • 6.7 ALGAL-BASED EXPRESSION SYSTEMS
    • 6.7.1 GROWTH IN VACCINES MARKET TO SUPPORT SEGMENT
    • TABLE 96 PROTEIN EXPRESSION MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 97 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 98 EUROPE: PROTEIN EXPRESSION MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 99 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 100 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS, BY REGION, 2020-2027 (USD MILLION)

7 PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE

  • 7.1 INTRODUCTION
    • TABLE 101 PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
  • 7.2 REAGENTS
    • 7.2.1 REAGENTS TO DOMINATE MARKET DURING FORECAST PERIOD
    • TABLE 102 PROTEIN EXPRESSION REAGENTS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 103 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR REAGENTS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 104 EUROPE: PROTEIN EXPRESSION MARKET FOR REAGENTS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 105 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR REAGENTS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 106 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR REAGENTS, BY REGION, 2020-2027 (USD MILLION)
  • 7.3 EXPRESSION VECTORS
    • 7.3.1 EXPRESSION VECTORS TO BE INDISPENSABLE FOR PROTEIN EXPRESSION
    • TABLE 107 PROTEIN EXPRESSION MARKET FOR EXPRESSION VECTORS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 108 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR EXPRESSION VECTORS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 109 EUROPE: PROTEIN EXPRESSION MARKET FOR EXPRESSION VECTORS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 110 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR EXPRESSION VECTORS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 111 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR EXPRESSION VECTORS, BY REGION, 2020-2027 (USD MILLION)
  • 7.4 COMPETENT CELLS
    • 7.4.1 INCREASING DEMAND FOR THERAPEUTIC PROTEINS TO DRIVE MARKET
    • TABLE 112 PROTEIN EXPRESSION MARKET FOR COMPETENT CELLS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 113 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR COMPETENT CELLS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 114 EUROPE: PROTEIN EXPRESSION MARKET FOR COMPETENT CELLS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 115 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR COMPETENT CELLS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 116 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR COMPETENT CELLS, BY REGION, 2020-2027 (USD MILLION)
  • 7.5 INSTRUMENTS
    • 7.5.1 INSTRUMENTS TO EFFICIENTLY TRANSFER GENETIC MATERIALS INTO HOST CELLS
    • TABLE 117 PROTEIN EXPRESSION MARKET FOR INSTRUMENTS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 118 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR INSTRUMENTS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 119 EUROPE: PROTEIN EXPRESSION MARKET FOR INSTRUMENTS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 120 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR INSTRUMENTS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 121 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR INSTRUMENTS, BY REGION, 2020-2027 (USD MILLION)
  • 7.6 SERVICES
    • 7.6.1 RISING DEMAND FOR CUSTOMIZED PROTEINS TO PROPEL MARKET
    • TABLE 122 PROTEIN EXPRESSION MARKET FOR SERVICES, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 123 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR SERVICES, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 124 EUROPE: PROTEIN EXPRESSION MARKET FOR SERVICES, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 125 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR SERVICES, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 126 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR SERVICES, BY REGION, 2020-2027 (USD MILLION)

8 PROTEIN EXPRESSION MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 127 PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
  • 8.2 THERAPEUTIC APPLICATIONS
    • 8.2.1 THERAPEUTIC PROTEINS TO TREAT PATHOLOGICAL CONDITIONS
    • TABLE 128 THERAPEUTIC PROTEINS AND INDICATION
    • TABLE 129 PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 130 NORTH AMERICA: THERAPEUTIC APPLICATIONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 131 EUROPE: THERAPEUTIC APPLICATIONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 132 ASIA PACIFIC: THERAPEUTIC APPLICATIONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 133 REST OF THE WORLD: THERAPEUTIC APPLICATIONS MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 8.3 RESEARCH APPLICATIONS
    • 8.3.1 INCREASING INVESTMENTS IN RESEARCH ACTIVITIES TO DRIVE SEGMENT
    • TABLE 134 PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 135 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 136 EUROPE: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 137 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 138 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2020-2027 (USD MILLION)
  • 8.4 INDUSTRIAL APPLICATIONS
    • 8.4.1 GROWTH IN EXPRESSION SYSTEMS FOR INDUSTRIAL ENZYMES PRODUCTION TO SUPPORT SEGMENT
    • TABLE 139 PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 140 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 141 EUROPE: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 142 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 143 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2020-2027 (USD MILLION)

9 PROTEIN EXPRESSION MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 144 PROTEIN EXPRESSION MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 9.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE END USERS MARKET
    • TABLE 145 PROTEIN EXPRESSION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 146 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 147 EUROPE: PROTEIN EXPRESSION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 148 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 149 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2020-2027 (USD MILLION)
  • 9.3 ACADEMIC RESEARCH INSTITUTES
    • 9.3.1 INCREASING GOVERNMENT AND PRIVATE FUNDING TO SUPPORT MARKET
    • TABLE 150 PROTEIN EXPRESSION MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 151 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 152 EUROPE: PROTEIN EXPRESSION MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 153 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 154 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2020-2027 (USD MILLION)
  • 9.4 CONTRACT RESEARCH ORGANIZATIONS & CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS (CROS & CDMOS)
    • 9.4.1 CLINICAL TRIALS, OUTSOURCING, AND COLLABORATIONS FOR PHARMACEUTICAL MANUFACTURING TO BOOST MARKET
    • TABLE 155 PROTEIN EXPRESSION MARKET FOR CROS & CDMOS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 156 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR CROS & CDMOS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 157 EUROPE: PROTEIN EXPRESSION MARKET FOR CROS & CDMOS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 158 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CROS & CDMOS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 159 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR CROS & CDMOS, BY REGION, 2020-2027 (USD MILLION)
  • 9.5 OTHER END USERS
    • TABLE 160 PROTEIN EXPRESSION MARKET FOR OTHER END USERS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 161 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER END USERS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 162 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER END USERS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 163 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER END USERS, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 164 ROW: PROTEIN EXPRESSION MARKET FOR OTHER END USERS, BY REGION, 2020-2027 (USD MILLION)

10 PROTEIN EXPRESSION MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 165 PROTEIN EXPRESSION MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 28 NORTH AMERICA: PROTEIN EXPRESSION MARKET SNAPSHOT
    • TABLE 166 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 167 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020-2027 (USD MILLION)
    • TABLE 168 NORTH AMERICA: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 169 NORTH AMERICA: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 170 NORTH AMERICA: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 171 NORTH AMERICA: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 172 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 173 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 174 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 US to dominate global protein expression market
    • TABLE 175 US: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020-2027 (USD MILLION)
    • TABLE 176 US: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 177 US: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 178 US: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 179 US: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 180 US: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 181 US: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 182 US: PROTEIN EXPRESSION MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Government funding for research and innovation to support market
    • TABLE 183 CANADA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020-2027 (USD MILLION)
    • TABLE 184 CANADA: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 185 CANADA: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 186 CANADA: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 187 CANADA: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 188 CANADA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 189 CANADA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 190 CANADA: PROTEIN EXPRESSION MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 10.3 EUROPE
    • TABLE 191 EUROPE: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 192 EUROPE: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020-2027 (USD MILLION)
    • TABLE 193 EUROPE: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 194 EUROPE: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 195 EUROPE: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 196 EUROPE: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 197 EUROPE: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 198 EUROPE: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 199 EUROPE: PROTEIN EXPRESSION MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Germany to dominate market share in Europe
    • TABLE 200 GERMANY: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020-2027 (USD MILLION)
    • TABLE 201 GERMANY: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 202 GERMANY: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 203 GERMANY: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 204 GERMANY: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 205 GERMANY: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 206 GERMANY: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 207 GERMANY: PROTEIN EXPRESSION MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.3.2 UK
      • 10.3.2.1 Surge in number of chronic diseases to boost market
    • TABLE 208 UK: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020-2027 (USD MILLION)
    • TABLE 209 UK: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 210 UK: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 211 UK: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 212 UK: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 213 UK: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 214 UK: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 215 UK: PROTEIN EXPRESSION MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 Increasing biotech R&D to drive market
    • TABLE 216 FRANCE: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020-2027 (USD MILLION)
    • TABLE 217 FRANCE: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 218 FRANCE: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 219 FRANCE: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 220 FRANCE: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 221 FRANCE: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 222 FRANCE: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 223 FRANCE: PROTEIN EXPRESSION MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Increase in life sciences research projects to fuel market
    • TABLE 224 ITALY: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020-2027 (USD MILLION)
    • TABLE 225 ITALY: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 226 ITALY: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 227 ITALY: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 228 ITALY: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 229 ITALY: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 230 ITALY: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 231 ITALY: PROTEIN EXPRESSION MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.3.5 SPAIN
      • 10.3.5.1 Network of research centers, universities, and hospitals to propel market
    • TABLE 232 SPAIN: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020-2027 (USD MILLION)
    • TABLE 233 SPAIN: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 234 SPAIN: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 235 SPAIN: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 236 SPAIN: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 237 SPAIN: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 238 SPAIN: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 239 SPAIN: PROTEIN EXPRESSION MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.3.6 REST OF EUROPE
    • TABLE 240 REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020-2027 (USD MILLION)
    • TABLE 241 REST OF EUROPE: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 242 REST OF EUROPE: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 243 REST OF EUROPE: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 244 REST OF EUROPE: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 245 REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 246 REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 247 REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 29 ASIA PACIFIC: PROTEIN EXPRESSION MARKET SNAPSHOT
    • TABLE 248 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 249 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020-2027 (USD MILLION)
    • TABLE 250 ASIA PACIFIC: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 251 ASIA PACIFIC: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 252 ASIA PACIFIC: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 253 ASIA PACIFIC: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 254 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 255 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 256 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.4.1 CHINA
      • 10.4.1.1 Growth in R&D to enhance technological capabilities
    • TABLE 257 CHINA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020-2027 (USD MILLION)
    • TABLE 258 CHINA: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 259 CHINA: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 260 CHINA: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 261 CHINA: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 262 CHINA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 263 CHINA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 264 CHINA: PROTEIN EXPRESSION MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.4.2 JAPAN
      • 10.4.2.1 Increasing protein-based research to stimulate market
    • TABLE 265 JAPAN: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020-2027 (USD MILLION)
    • TABLE 266 JAPAN: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 267 JAPAN: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 268 JAPAN: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 269 JAPAN: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 270 JAPAN: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 271 JAPAN: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 272 JAPAN: PROTEIN EXPRESSION MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Increasing government support to drive market
    • TABLE 273 INDIA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020-2027 (USD MILLION)
    • TABLE 274 INDIA: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 275 INDIA: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 276 INDIA: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 277 INDIA: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 278 INDIA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 279 INDIA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 280 INDIA: PROTEIN EXPRESSION MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.4.4 AUSTRALIA
      • 10.4.4.1 Increasing focus of healthcare system on precision medicine to fuel market
    • TABLE 281 AUSTRALIA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020-2027 (USD MILLION)
    • TABLE 282 AUSTRALIA: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 283 AUSTRALIA: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 284 AUSTRALIA: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 285 AUSTRALIA: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 286 AUSTRALIA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 287 AUSTRALIA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 288 AUSTRALIA: PROTEIN EXPRESSION MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.4.5 REST OF ASIA PACIFIC
    • TABLE 289 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020-2027 (USD MILLION)
    • TABLE 290 REST OF ASIA PACIFIC: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 291 REST OF ASIA PACIFIC: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 292 REST OF ASIA PACIFIC: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 293 REST OF ASIA PACIFIC: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 294 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 295 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 296 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 10.5 REST OF THE WORLD
    • TABLE 297 REST OF THE WORLD: PROTEIN EXPRESSION MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 298 REST OF THE WORLD: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020-2027 (USD MILLION)
    • TABLE 299 REST OF THE WORLD: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 300 REST OF THE WORLD: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 301 REST OF THE WORLD: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 302 REST OF THE WORLD: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 303 REST OF THE WORLD: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 304 REST OF THE WORLD: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 305 REST OF THE WORLD: PROTEIN EXPRESSION MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.5.1 LATIN AMERICA
      • 10.5.1.1 Growth in biopharmaceutical industry to support market
    • TABLE 306 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020-2027 (USD MILLION)
    • TABLE 307 LATIN AMERICA: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 308 LATIN AMERICA: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 309 LATIN AMERICA: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 310 LATIN AMERICA: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 311 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 312 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 313 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.5.2 MIDDLE EAST & AFRICA
      • 10.5.2.1 Increasing government investments in healthcare sector and growing pharmaceuticals industry to support market
    • TABLE 314 MIDDLE EAST & AFRICA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020-2027 (USD MILLION)
    • TABLE 315 MIDDLE EAST & AFRICA: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 316 MIDDLE EAST & AFRICA: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 317 MIDDLE EAST & AFRICA: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 318 MIDDLE EAST & AFRICA: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 319 MIDDLE EAST & AFRICA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 320 MIDDLE EAST & AFRICA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 321 MIDDLE EAST & AFRICA: PROTEIN EXPRESSION MARKET, BY END USER, 2020-2027 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 11.3 MARKET SHARE ANALYSIS
    • TABLE 322 PROTEIN EXPRESSION MARKET: DEGREE OF COMPETITION
  • 11.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
  • 11.5 COMPANY EVALUATION QUADRANT
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • FIGURE 33 PROTEIN EXPRESSION MARKET: COMPANY EVALUATION QUADRANT, 2021
  • 11.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 STARTING BLOCKS
    • 11.6.3 RESPONSIVE COMPANIES
    • 11.6.4 DYNAMIC COMPANIES
    • FIGURE 34 PROTEIN EXPRESSION MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2021
  • 11.7 COMPANY FOOTPRINT ANALYSIS
    • 11.7.1 PRODUCT FOOTPRINT OF COMPANIES
    • TABLE 323 PRODUCT AND SERVICE FOOTPRINT OF COMPANIES IN PROTEIN EXPRESSION MARKET (2021)
  • 11.8 REGIONAL FOOTPRINT OF COMPANIES
    • TABLE 324 REGIONAL FOOTPRINT OF COMPANIES IN PROTEIN EXPRESSION MARKET (2021)
  • 11.9 COMPETITIVE BENCHMARKING OF START-UPS/SME PLAYERS
    • TABLE 325 PROTEIN EXPRESSION MARKET: DETAILED LIST OF KEY START-UPS/SME PLAYERS
  • 11.10 COMPETITIVE SCENARIO
    • TABLE 326 KEY PRODUCT/ SERVICE LAUNCHES
    • TABLE 327 KEY DEALS
    • TABLE 328 EXPANSION

12 COMPANY PROFILES

  • (Business overview, Products/Services/Solutions offered, Recent Developments, MNM view)**
  • 12.1 KEY PLAYERS
    • 12.1.1 THERMO FISHER SCIENTIFIC, INC.
    • TABLE 329 THERMO FISHER SCIENTIFIC, INC.: COMPANY OVERVIEW
    • FIGURE 35 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021)
    • 12.1.2 MERCK KGAA
    • TABLE 330 MERCK KGAA: COMPANY OVERVIEW
    • FIGURE 36 MERCK KGAA: COMPANY SNAPSHOT
    • 12.1.3 GENSCRIPT BIOTECH CORPORATION
    • TABLE 331 GENSCRIPT BIOTECH CORPORATION: BUSINESS OVERVIEW
    • FIGURE 37 GENSCRIPT BIOTECH CORPORATION: COMPANY SNAPSHOT (2021)
    • 12.1.4 AGILENT TECHNOLOGIES INC.
    • TABLE 332 AGILENT TECHNOLOGIES INC.: COMPANY OVERVIEW
    • FIGURE 38 AGILENT TECHNOLOGIES INC.: COMPANY SNAPSHOT (2021)
    • 12.1.5 TAKARA BIO, INC.
    • TABLE 333 TAKARA BIO, INC.: COMPANY OVERVIEW
    • FIGURE 39 TAKARA BIO, INC.: COMPANY SNAPSHOT (2021)
    • 12.1.6 BIO-RAD LABORATORIES, INC.
    • TABLE 334 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
    • FIGURE 40 TAKARA BIO, INC.: COMPANY SNAPSHOT (2021)
    • 12.1.7 QIAGEN N.V.
    • TABLE 335 QIAGEN N.V.: COMPANY OVERVIEW
    • FIGURE 41 QIAGEN N.V..: COMPANY SNAPSHOT (2021)
    • 12.1.8 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
    • TABLE 336 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY OVERVIEW
    • FIGURE 42 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT (2021)
    • 12.1.9 DANAHER CORPORATION
    • TABLE 337 DANAHER CORPORATION: COMPANY OVERVIEW
    • FIGURE 43 DANAHER CORPORATION: COMPANY SNAPSHOT
    • 12.1.10 SARTORIUS AG
    • TABLE 338 SARTORIUS AG: COMPANY OVERVIEW
    • FIGURE 44 SARTORIUS AG: COMPANY SNAPSHOT
    • 12.1.11 CORNING INCORPORATED
    • TABLE 339 CORNING INCORPORATED: COMPANY OVERVIEW
    • FIGURE 45 CORNING INCORPORATED: COMPANY SNAPSHOT
    • 12.1.12 FUJIFILM IRVINE SCIENTIFIC, INC. (ACQUIRED BY FUJIFILM HOLDINGS CORPORATION)
    • TABLE 340 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW
    • FIGURE 46 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
    • 12.1.13 LONZA GROUP AG
    • TABLE 341 LONZA GROUP AG: COMPANY OVERVIEW
    • FIGURE 47 LONZA GROUP AG: COMPANY SNAPSHOT (2021)
    • 12.1.14 BIONEER CORPORATION
    • TABLE 342 BIONEER CORPORATION: COMPANY OVERVIEW
    • 12.1.15 PROMEGA CORPORATION
    • TABLE 343 PROMEGA CORPORATION: COMPANY OVERVIEW
    • 12.1.16 OXFORD EXPRESSION TECHNOLOGIES LTD.
    • TABLE 344 OXFORD EXPRESSION TECHNOLOGIES LTD.: COMPANY OVERVIEW
    • 12.1.17 PROTEOGENIX
    • TABLE 345 PROTEOGENIX: COMPANY OVERVIEW
    • 12.1.18 ABEOMICS INC.
    • TABLE 346 ABEOMICS INC.: COMPANY OVERVIEW
    • 12.1.19 NEW ENGLAND BIOLABS, INC.
    • TABLE 347 NEW ENGLAND BIOLABS, INC.: COMPANY OVERVIEW
  • 12.2 OTHER PLAYERS
    • 12.2.1 PROMAB BIOTECHNOLOGIES
    • 12.2.2 SINO BIOLOGICAL, INC.
    • 12.2.3 JENA BIOSCIENCE
    • 12.2.4 LIFESENSORS, INC.
    • 12.2.5 LEADING BIOLOGY, INC.
    • 12.2.6 PEAK PROTEINS
  • *Details on Business overview, Products/Services/Solutions offered, Recent Developments, MNM view might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 AVAILABLE CUSTOMIZATIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!